Sho Saito

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Mesenchymal Stem Cells

Klebsiella Pneumoniae

Top Venues

JMIR research protocols

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Rina Yano, Junko Terada-Hirashima, Yukari Uemura, Noriko Tomita, Yosuke Shimizu, Haruka Iwasaki, Nobumasa Okumura, Tetsuya Suzuki, Sho Saito, Mugen Ujiie, Wataru Sugiura, Norio Ohmagari
Efficacy and Safety of the Smallpox Vaccine for Postexposure Prophylaxis in Monkeypox: Protocol for an Open-Labeled, Single-Armed Study. JMIR research protocols 12 (2023)
Tetsuya Suzuki, Sho Saito, Shinya Tsuzuki, Shinobu Ashida, Mizue Takakusaki, Tomoki Yoshikawa, Masayuki Shimojima, Hideki Ebihara, Norio Ohmagari, Shinichiro Morioka
Protocol of Tecopox study: a multicentre, open-label, double-arm trial to evaluate the efficacy and safety of oral tecovirimat therapy for patients with smallpox or monkeypox. BMJ open 13 (8) (2023)
Mari Terada, Hiroshi Ohtsu, Sho Saito, Kayoko Hayakawa, Shinya Tsuzuki, Yusuke Asai, Nobuaki Matsunaga, Satoshi Kutsuna, Wataru Sugiura, Norio Ohmagari
Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan. BMJ open 11 (6) (2021)
Sho Saito, Kayoko Hayakawa, Shinya Tsuzuki, Masahiro Ishikane, Maki Nagashima, Kazuhisa Mezaki, Yuko Sugiki, Taichi Tajima, Nobuaki Matsunaga, Satoshi Ide, Noriko Kinoshita, Yoshiki Kusama, Yumiko Fujitomo, Takato Nakamoto, Yuta Toda, Mitsuo Kaku, Eiichi N Kodama, Norio Ohmagari
A Matched Case-Case-Control Study of the Impact of Clinical Outcomes and Risk Factors of Patients with IMP-Type Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae in Japan. Antimicrobial agents and chemotherapy 65 (3) (2021)